# Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug Treatment

> **NCT00707382** · NA · COMPLETED · sponsor: **Gesche Jurgens** · enrollment: 311 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **GENETIC:** (1) Genotyping for CYP4502D6 and 2C19 polymorphisms
- **OTHER:** (2) Intense clinical monitoring
- **OTHER:** (3) Control

## Key facts

- **NCT ID:** NCT00707382
- **Lead sponsor:** Gesche Jurgens
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 311 (ACTUAL)
- **Last updated:** 2012-02-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00707382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00707382, "Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug Treatment". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00707382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*